The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy

被引:13
作者
Allavena, Paola [1 ]
Marchesi, Federica [1 ]
Mantovani, Alberto [1 ,2 ]
机构
[1] Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy
[2] Univ Milan, Inst Gen Pathol, Ctr IDET, I-20133 Milan, Italy
关键词
Chemokines; chemokine receptors; chemotaxis; tumor-associated macrophages; tumor-infiltrating leukocytes; tumor stroma; angiogenesis; matrix-metalloproteases; tumor survival; metastasis;
D O I
10.2174/1573394052952483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemotactic cytokines (chemokines) are a family of small proteins inducing directed cell migration (chemotaxis), via specific G-protein coupled receptors. Initially described as molecules regulating leukocyte recruitment at sites of inflammation, in the last decade, it has become increasingly clear that chemokines mediate several other functions and therefore are more than simple traffick controllers. Chemokines are produced by many different cell types, including tumor cells. Indeed, tumors are major producer of chemokines and have represented an invaluable source for their identification and characterization. In the tumor microenvironment chemokines are crucial regulators of the levels of tumor-infiltrating leukocytes. In addition, these mediators control a variety of biological activities, such as production and deposition of collagen, activation of matrix-digesting enzymes, stimulation of cell growth, inhibition of apoptosis and promotion of neo-angiogenesis. The expression of chemokines, therefore, is of potential advantage for tumor cells and may endow them with enhanced ability to proliferate and disseminate. The complex network of chemokines and their receptors in the tumor microenvironment is currently the object of an intense investigation aimed at targeting these molecules for therapeutic interventions.
引用
收藏
页码:81 / 92
页数:12
相关论文
共 148 条
[1]   The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis [J].
Addison, CL ;
Arenberg, DA ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Mulligan, MS ;
Iannettoni, MD ;
Strieter, RM .
HUMAN GENE THERAPY, 2000, 11 (02) :247-261
[2]   Viral mimicry of cytokines, chemokines and their receptors [J].
Alcami, A .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) :36-50
[3]   The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues [J].
Allavena, P ;
Sica, A ;
Vecchi, A ;
Locati, M ;
Sozzani, S ;
Mantovani, A .
IMMUNOLOGICAL REVIEWS, 2000, 177 :141-149
[4]  
Ardavin Carlos, 2004, Immunity, V20, P17, DOI 10.1016/S1074-7613(03)00352-2
[5]   Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer [J].
Arenberg, DA ;
Keane, MP ;
DiGiovine, B ;
Kunkel, SL ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Glass, MC ;
Iannettoni, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :465-472
[6]  
Azenshtein E, 2002, CANCER RES, V62, P1093
[7]  
Bachelder RE, 2002, CANCER RES, V62, P7203
[8]  
BALENTIEN E, 1991, ONCOGENE, V6, P1115
[9]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[10]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545